Skip to main content
. 2015 Apr 8;9:78. doi: 10.1186/s13256-015-0552-5

Table 2.

Diagnostic criteria for hemophagocytic syndrome according to trial HLH-2004

Confirmed molecular disease: PRF1 mutation, UNC13D, Munc 18-2, Rab27a, STX11, SH2D1A, BIRC4
Five of eight clinical and laboratory criteria: 1. Fever
2. Splenomegaly
3. Cytopenia affecting two or more cell lines:
• Hemoglobin <9g/dL
• Platelets <100,000/mL
• Neutrophils <1000/mL
4. Hypertriglyceridemia (fasting triglycerides >265mg/dL or 3mMol/L) and or hypofibrinogenemia (<150mg/dL)
5. Hemophagocytosis in bone marrow, spleen, liver, lymph node, skin
6. Decreased or absent natural killer cell activity
7. Ferritin >500ng/mLa
8. Soluble CD25 >2400U/mL

aFerritin greater than 10,000ng/mL is almost confirmatory.